Trial intelligence / Profile preview

Riociguat and biperiden crossover study of cognition in healthy volunteers

NL-OMON22467Recruiting

Sponsor
Maastricht University
Start
Feb 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of riociguat and biperiden (4 arms), sponsored by Maastricht University. Primary endpoint: Behavioral scores on verbal learning task. Started Feb 2016; status: recruiting.

02

Drugs

riociguatbiperiden

Beyond the preview

Go deeper on NL-OMON22467.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON22467.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call